1
|
Borges LP, Barreto MDS, Santos RS, Souza JBDE, Silva BSDA, Jesus PCDE, Silva DMRR, Moura PHM, Santos LMMD, Silva EED, Santana LADAM. Why are measles and rubella returning in Brazil? AN ACAD BRAS CIENC 2023; 95:e20230832. [PMID: 38055566 DOI: 10.1590/0001-3765202320230832] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/28/2023] [Accepted: 08/28/2023] [Indexed: 12/08/2023] Open
Affiliation(s)
- Lysandro P Borges
- Federal University of Sergipe, Department of Pharmacy, Av. Marechal Rondon Jardim, s/n, Rosa Elze, 49100-000 São Cristóvão, SE, Brazil
| | - Marina Dos S Barreto
- Federal University of Sergipe, Department of Pharmacy, Av. Marechal Rondon Jardim, s/n, Rosa Elze, 49100-000 São Cristóvão, SE, Brazil
| | - Ronaldy S Santos
- Federal University of Sergipe, Department of Pharmacy, Av. Marechal Rondon Jardim, s/n, Rosa Elze, 49100-000 São Cristóvão, SE, Brazil
| | - Jessiane B DE Souza
- Federal University of Sergipe, Department of Pharmacy, Av. Marechal Rondon Jardim, s/n, Rosa Elze, 49100-000 São Cristóvão, SE, Brazil
| | - Beatriz S DA Silva
- Federal University of Sergipe, Department of Pharmacy, Av. Marechal Rondon Jardim, s/n, Rosa Elze, 49100-000 São Cristóvão, SE, Brazil
| | - Pamela C DE Jesus
- Federal University of Sergipe, Department of Pharmacy, Av. Marechal Rondon Jardim, s/n, Rosa Elze, 49100-000 São Cristóvão, SE, Brazil
| | - Deise M R R Silva
- Federal University of Sergipe, Department of Pharmacy, Av. Marechal Rondon Jardim, s/n, Rosa Elze, 49100-000 São Cristóvão, SE, Brazil
| | - Pedro H M Moura
- Federal University of Sergipe, Department of Pharmacy, Av. Marechal Rondon Jardim, s/n, Rosa Elze, 49100-000 São Cristóvão, SE, Brazil
| | - Leticia M M Dos Santos
- Federal University of Sergipe, Department of Pharmacy, Av. Marechal Rondon Jardim, s/n, Rosa Elze, 49100-000 São Cristóvão, SE, Brazil
| | - Eloia E D Silva
- Federal University of Sergipe, Department of Biological Sciences, Av. Marechal Rondon Jardim, s/n, Rosa Elze, 49100-000 São Cristóvão, SE, Brazil
| | - Lucas A DA M Santana
- Federal University of Sergipe, Graduate Program in Dentistry, Health and Biological Sciences Institute, St. Cláudio Batista, s/n, Cidade Nova, 49060-102 Aracaju, SE, Brazil
| |
Collapse
|
2
|
Araujo BC, Simakawa R, Munhoz LG, Carmo FB, de Menezes Succi RC, de Moraes-Pinto MI. Rubella antibodies in vertically and horizontally HIV-infected young adults vaccinated early in life and response to a booster dose in those with seronegative results. Vaccine 2022; 40:4496-4502. [PMID: 35717264 DOI: 10.1016/j.vaccine.2022.06.025] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/23/2021] [Revised: 06/05/2022] [Accepted: 06/06/2022] [Indexed: 10/18/2022]
Abstract
BACKGROUND Very limited data are available on the persistence of rubella antibodies in vertically HIV-infected individuals who were vaccinated early in life. METHODS Prospective, cohort study on 4 groups of patients: 96 vertically HIV-1-infected individuals (v-HIV), 69 horizontally HIV-1-infected individuals (h-HIV), 93 healthy controls previously vaccinated for rubella (vac-CON) and 20 healthy controls with history of rubella disease (dis-CON). A blood sample was collected and rubella antibodies were analyzed by ELISA. Rubella antibodies above 10 IU/mL were considered protective. Individuals with seronegative results were offered an extra MMR vaccine dose and were tested at least 30 days afterwards. RESULTS Time since previous rubella vaccination was similar in v-HIV, h-HIV and vac-CON (16, 11 and 11 years; p = 0.428). v-HIV and h-HIV were also comparable regarding median CD4 T cells (613 and 614 cells/mm3; p = 0.599) and percentage on ART (93.8% and 98.6%; p = 0.135) at study entry. v-HIV had less individuals on virological suppression (63.5%) compared to 85.5% in h-HIV (p < 0.001). Rubella seropositivity and antibodies were significantly lower in v-HIV compared to h-HIV (32.3% vs 65.5%, 4.3 IU/mL vs 21.1 IU/mL; p < 0.001). Time interval between the last rubella vaccine dose and study entry was associated with an increase of rubella seronegativity, with a 7% higher chance of seronegativity for each one-year increase. After an extra MMR dose, 40 out of 48 (83.3%) seronegative individuals responded, with no significant difference among groups considering rubella seropositivity and antibody levels. CONCLUSION As vertically HIV-infected individuals reach adolescence and adulthood, assessment of vaccine antibodies can identify those who might benefit from an extra vaccine dose.
Collapse
Affiliation(s)
- Beatriz Collaço Araujo
- Division of Pediatric Infectious Diseases, Department of Pediatrics, Escola Paulista de Medicina, Universidade Federal de São Paulo - UNIFESP, São Paulo, Brazil
| | - Raquel Simakawa
- Division of Pediatric Infectious Diseases, Department of Pediatrics, Escola Paulista de Medicina, Universidade Federal de São Paulo - UNIFESP, São Paulo, Brazil
| | - Luiz Gustavo Munhoz
- Division of Pediatric Infectious Diseases, Department of Pediatrics, Escola Paulista de Medicina, Universidade Federal de São Paulo - UNIFESP, São Paulo, Brazil
| | - Fabiana B Carmo
- Division of Pediatric Infectious Diseases, Department of Pediatrics, Escola Paulista de Medicina, Universidade Federal de São Paulo - UNIFESP, São Paulo, Brazil
| | - Regina Célia de Menezes Succi
- Division of Pediatric Infectious Diseases, Department of Pediatrics, Escola Paulista de Medicina, Universidade Federal de São Paulo - UNIFESP, São Paulo, Brazil
| | - Maria Isabel de Moraes-Pinto
- Division of Pediatric Infectious Diseases, Department of Pediatrics, Escola Paulista de Medicina, Universidade Federal de São Paulo - UNIFESP, São Paulo, Brazil.
| |
Collapse
|
3
|
Patel MK, Antoni S, Danovaro-Holliday MC, Desai S, Gacic-Dobo M, Nedelec Y, Kretsinger K. The epidemiology of rubella, 2007–18: an ecological analysis of surveillance data. LANCET GLOBAL HEALTH 2020; 8:e1399-e1407. [DOI: 10.1016/s2214-109x(20)30320-x] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/19/2020] [Revised: 06/26/2020] [Accepted: 06/30/2020] [Indexed: 10/23/2022]
|
4
|
Edelstein M, White J, Bukasa A, Saliba V, Ramsay M. Triangulation of measles vaccination data in the United Kingdom of Great Britain and Northern Ireland. Bull World Health Organ 2019; 97:754-763. [PMID: 31673191 PMCID: PMC6802697 DOI: 10.2471/blt.18.229138] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/27/2018] [Revised: 06/07/2019] [Accepted: 06/19/2019] [Indexed: 11/27/2022] Open
Abstract
Objective To illustrate how data triangulation involving routine data sources can optimize data usage and provide insights into vaccine programme effectiveness by considering measles vaccination and disease incidence data in England. Methods We obtained data on measles, mumps and rubella (MMR) vaccine coverage in birth cohorts from 1985 to 2016 from child health records and adjusted for under-ascertainment and catch-up campaigns. We assumed that the population had no natural immunity and that vaccine effectiveness was 95% for one dose and 99.75% for two doses. Vaccinations done outside the routine schedule and in people who entered England after the age of immunization were identified from primary care records. Measles susceptibility was defined as the percentage of individuals who were not immune despite all vaccination activities. We triangulated measles susceptibility and incidence data. Findings Median susceptibility was 4.6% (range: 1.2–9.2). Among cohorts eligible for two MMR vaccine doses, those born between 1998 and 2004 were most susceptible. Measles incidence was highest in these cohorts. Data from primary care and child health records were comparable for cohorts after 2000, suggesting that little supplementary vaccination took place. For cohorts before 2000, primary care data quality was insufficient for accurately estimating coverage. Conclusion Triangulating routine data on measles vaccination coverage and disease surveillance provided new insights into population immunity and helped identify vulnerable groups, which was useful for prioritizing public health actions to close gaps in immunity. This approach could be applied in any country that routinely records vaccine coverage and disease incidence.
Collapse
Affiliation(s)
- Michael Edelstein
- National Infection Service, Public Health England, 61 Colindale Avenue, London NW9 5EQ, England
| | - Joanne White
- National Infection Service, Public Health England, 61 Colindale Avenue, London NW9 5EQ, England
| | - Antoaneta Bukasa
- National Infection Service, Public Health England, 61 Colindale Avenue, London NW9 5EQ, England
| | - Vanessa Saliba
- National Infection Service, Public Health England, 61 Colindale Avenue, London NW9 5EQ, England
| | - Mary Ramsay
- National Infection Service, Public Health England, 61 Colindale Avenue, London NW9 5EQ, England
| |
Collapse
|
5
|
Nóbrega YKM, de Carvalho BC, Nitz N, Vital TE, Leite FB, Sequeira IJ, Moreira EE, de Andrade JKB, Gandolfi L, Pratesi R, Hecht MM. Rubella Seropositivity in Pregnant Women After Vaccination Campaign in Brazil's Federal District. Viral Immunol 2017; 30:675-677. [PMID: 28972455 DOI: 10.1089/vim.2017.0012] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Rubella is an acute viral disease that usually does not generate sequels; however, in pregnant women the infection can cause serious abnormalities to fetuses, which are collectively called congenital rubella syndrome. In Brazil, population immunization was started in 1992, but few epidemiological studies have been conducted to assess vaccination coverage and seroconversion since then. The aim of this work is to evaluate the seropositivity of pregnant women to rubella virus after vaccination campaign was carried out in 2008. Serological tests for rubella diagnosis were performed in 87 pregnant women who attended the University of Brasilia Hospital, Federal District, Brazil. Antirubella IgG antibodies were detected in 83 out of 87 pregnant women (95.4%), with an age-independent seroprevalence. Only one woman was positive in IgM serological tests. Our data suggest high levels of vaccination coverage and antirubella immunization in the Brazil Federal District population.
Collapse
Affiliation(s)
- Yanna K M Nóbrega
- 1 Immunogenetic and Chronic-Degenerative Diseases Laboratory, School of Medicine, University of Brasilia , Brasilia, Brazil
| | - Bruna C de Carvalho
- 2 Methodologies Applied to Infectious Diseases Laboratory, School of Medicine, University of Brasilia , Brasilia, Brazil
| | - Nadjar Nitz
- 2 Methodologies Applied to Infectious Diseases Laboratory, School of Medicine, University of Brasilia , Brasilia, Brazil
| | - Tamires E Vital
- 2 Methodologies Applied to Infectious Diseases Laboratory, School of Medicine, University of Brasilia , Brasilia, Brazil
| | - Franco B Leite
- 3 Clinical Analysis Laboratory, Immunology Sector, University of Brasilia Hospital, University of Brasilia , Brasilia, Brazil
| | - Inês J Sequeira
- 4 Department of Mathematics, School Science and Technology, Mathematics and Applications Center, New University of Lisbon , Lisbon, Portugal
| | - Elsa E Moreira
- 4 Department of Mathematics, School Science and Technology, Mathematics and Applications Center, New University of Lisbon , Lisbon, Portugal
| | - Juliana K B de Andrade
- 1 Immunogenetic and Chronic-Degenerative Diseases Laboratory, School of Medicine, University of Brasilia , Brasilia, Brazil
| | - Lenora Gandolfi
- 1 Immunogenetic and Chronic-Degenerative Diseases Laboratory, School of Medicine, University of Brasilia , Brasilia, Brazil
| | - Riccardo Pratesi
- 1 Immunogenetic and Chronic-Degenerative Diseases Laboratory, School of Medicine, University of Brasilia , Brasilia, Brazil
| | - Mariana M Hecht
- 2 Methodologies Applied to Infectious Diseases Laboratory, School of Medicine, University of Brasilia , Brasilia, Brazil
| |
Collapse
|
6
|
Francisco PMSB, Senicato C, Donalisio MR, Barros MBDA. Vacinação contra rubéola em mulheres em idade reprodutiva no Município de Campinas, São Paulo, Brasil. CAD SAUDE PUBLICA 2013; 29:579-88. [DOI: 10.1590/s0102-311x2013000300015] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/03/2012] [Accepted: 10/09/2012] [Indexed: 11/22/2022] Open
Abstract
As mulheres em idade reprodutiva são a população de maior interesse para a prevenção da síndrome da rubéola congênita. O objetivo do trabalho foi avaliar a prevalência de vacinação contra rubéola em mulheres e identificar fatores associados e motivos da não adesão. Trata-se de estudo transversal de base populacional, realizado em Campinas, São Paulo, Brasil, em 2008/2009, com amostra por conglomerados e em dois estágios. Das 778 mulheres de 10 a 49 anos, 83,8% (IC95%: 79,6-88,0) referiram vacinação em algum momento da vida. Faixa etária (30-39 anos), renda familiar per capita superior a três salários mínimos e a orientação de profissional de saúde estiveram positivamente associadas à vacinação contra a rubéola. Os principais motivos da não adesão foram a falta de orientação do profissional de saúde sobre sua importância (48,5%) e não considerá-la necessária (18,9%). A recomendação do profissional de saúde foi o fator mais fortemente associado à adesão das mulheres à vacinação. Nesse sentido, sua indicação pelas equipes de saúde pode ampliar o conhecimento sobre sua importância e seus benefícios.
Collapse
|